Table 2 Principal biomarkers in the study population
|  | Short disease group (n = 25) | Long disease group (n = 29) | Healthy group (n = 26) | p-value |
|---|---|---|---|---|
UfRBP4 (ug/mmol) | 1.13 (0.6, 2.1) | 1.15 (0.7, 1.6) | 1.16 (0.43, 1.81) | 0.7 |
Ualb (mg/mmol) | 0.6 (0.4, 0.8) | 0.4 (0.4, 0.9) | 0.7 (0.4, 1.0) | 0.5 |
KIM-1 (ng/mL) | 0.09 (0.04,0.15) | 0.06 (0.04,0.13) | 0.06 (0.04,0.08) | 0.07 |